Trending...
- Matt Stuckert Joins Lineus Medical Board of Directors
- ohGiGi® Wins Second Consecutive Sustainability Award, Addressing Plastic Waste in Oral Care
- Drone Light Shows Become the Must-Have Entertainment Trend for Events and Venues
AVENTURA, Fla. - AussieJournal -- Dr. Jeff Gelblum, Neurologist at First Choice Neurology, has brought together clinical, imaging, and laboratory capabilities to provide rapid diagnosis and treatment to individuals suffering from Alzheimer's disease.
The patient journey of Alzheimer's evaluation and management involves a clinical assessment to determine the level of cognitive impairment, and imaging studies of the brain, MRI, and PET scans to identify the presence of brain amyloid plaques. Also included are laboratory capabilities to inform the tolerability of the new anti-Alzheimer medication, and an experienced infusion team capable of providing the new class of FDA-approved medication in a comfortable setting.
Dr. Gelblum's highly integrated program will eliminate the long delays and fragmented care that typically plague patients seeking Alzheimer's treatment.
He observes, "that the new class of disease-modifying treatments are only approved in mild Alzheimer's which offers only a short window of opportunity to treat. In the US and abroad, it can often take up to a year to get a neurology appointment, and by that point, the patient may have progressed to a point where they might no longer respond to treatment."
More on Aussie Journal
Dr. Gelblum's program eliminates the delay and provides a quick and comprehensive work-up in the Aventura medical district, just north of Miami, Florida.
Dr. Gelblum boasts that "within 48 hours we can diagnose and begin infusion therapy. This means that the patient can check in to our on-campus hotel on a Tuesday evening, undergo evaluation in our clinic Wednesday morning, receive diagnostic testing Wednesday and Thursday, and then obtain their infusion treatment on Friday."
For those patients who reside out of town, his infusion center can dispense medication to-go for follow-up infusion treatments in their hometown medical facility. This is ideal for out-of-town patients who may not have easy access to a neurologist. He can then follow the patient remotely via telehealth.
His Aventura clinic is easily accessible via Miami or Fort Lauderdale international airports.
Dr. Gelblum has a global patient population who has discovered the ease of access and convenience of care provided by this program. He has patients from the UK, Spain, France, Israel, Russia, South Korea, Central and South America, and the Caribbean. They are diagnosed in his Aventura clinic and then followed up remotely via Skype, WhatsApp, FaceTime, or any manner of live audiovisual interface.
More on Aussie Journal
Dr. Gelblum observes, "that in this day and age of disease-modifying therapy and instantaneous telecommunications, it is unacceptable for medically necessary neurological care and treatment to be delayed."
He looks forward to welcoming Alzheimer patients from all over to his Aventura, Florida clinic.
About Jeffrey Gelblum, MD, FAAN
Dr. Jeff Gelblum is a neurologist with First Choice Neurology located in Aventura, Florida. He is considered a global thought leader in the neurologic treatment of Alzheimer's, dementia, seizure disorders, Parkinson's, diabetic and peripheral nerve disorder, Familial Amyloid Polyneuropathy, Covid Long-Hauler, trauma, and chronic pain, and has hosted educational symposia in the U.S. and overseas. To learn more about Dr. Gelblum, visit https://www.fcneurology.net/business-directory/788/jeffrey-gelblum-md/
The patient journey of Alzheimer's evaluation and management involves a clinical assessment to determine the level of cognitive impairment, and imaging studies of the brain, MRI, and PET scans to identify the presence of brain amyloid plaques. Also included are laboratory capabilities to inform the tolerability of the new anti-Alzheimer medication, and an experienced infusion team capable of providing the new class of FDA-approved medication in a comfortable setting.
Dr. Gelblum's highly integrated program will eliminate the long delays and fragmented care that typically plague patients seeking Alzheimer's treatment.
He observes, "that the new class of disease-modifying treatments are only approved in mild Alzheimer's which offers only a short window of opportunity to treat. In the US and abroad, it can often take up to a year to get a neurology appointment, and by that point, the patient may have progressed to a point where they might no longer respond to treatment."
More on Aussie Journal
- Energy-Efficient Heat Pump Systems: The Future of Sustainable Hot Water Solutions
- Northern Australia Contaminated Land and Groundwater Conference Returns to Darwin in May 2025
- Guests Can Save 15 Percent on a Florida Keys Vacation Home Rental with KeysCaribbean's 'Advance Purchase Discount'
- Elevate Local Launches to Help Tennessee Small Businesses Grow Online with Expert SEO and Digital Marketing
- Olga Torres Once Again Recognized as a Top Advisor by Foreign Investment Watch
Dr. Gelblum's program eliminates the delay and provides a quick and comprehensive work-up in the Aventura medical district, just north of Miami, Florida.
Dr. Gelblum boasts that "within 48 hours we can diagnose and begin infusion therapy. This means that the patient can check in to our on-campus hotel on a Tuesday evening, undergo evaluation in our clinic Wednesday morning, receive diagnostic testing Wednesday and Thursday, and then obtain their infusion treatment on Friday."
For those patients who reside out of town, his infusion center can dispense medication to-go for follow-up infusion treatments in their hometown medical facility. This is ideal for out-of-town patients who may not have easy access to a neurologist. He can then follow the patient remotely via telehealth.
His Aventura clinic is easily accessible via Miami or Fort Lauderdale international airports.
Dr. Gelblum has a global patient population who has discovered the ease of access and convenience of care provided by this program. He has patients from the UK, Spain, France, Israel, Russia, South Korea, Central and South America, and the Caribbean. They are diagnosed in his Aventura clinic and then followed up remotely via Skype, WhatsApp, FaceTime, or any manner of live audiovisual interface.
More on Aussie Journal
- $300 Million in Milestones; Double-Digit Royalties; Neurospa LOI for Expansion of International Psychiatry Clinics plus NDA Filed with FDA on New Drug
- Spartan Investigations Partners with Dallas Law Enforcement to Combat Human Trafficking
- Torture in the Troubled Teen Industry, Death by Deliberate Indifference Report
- Unlock Huge Savings with Commercial Heat Pump Installation Rebates in 2025
- Climate Green Melbourne Offers Energy-Efficient Commercial Heat Pump Installations Across Victoria
Dr. Gelblum observes, "that in this day and age of disease-modifying therapy and instantaneous telecommunications, it is unacceptable for medically necessary neurological care and treatment to be delayed."
He looks forward to welcoming Alzheimer patients from all over to his Aventura, Florida clinic.
About Jeffrey Gelblum, MD, FAAN
Dr. Jeff Gelblum is a neurologist with First Choice Neurology located in Aventura, Florida. He is considered a global thought leader in the neurologic treatment of Alzheimer's, dementia, seizure disorders, Parkinson's, diabetic and peripheral nerve disorder, Familial Amyloid Polyneuropathy, Covid Long-Hauler, trauma, and chronic pain, and has hosted educational symposia in the U.S. and overseas. To learn more about Dr. Gelblum, visit https://www.fcneurology.net/business-directory/788/jeffrey-gelblum-md/
Source: First Choice Neurology
Filed Under: Health
0 Comments
Latest on Aussie Journal
- The Ripple Effect Arts Leverages Social Media to Showcase the Benefits of Magic Magnesium Spray, Driving 200% Audience Growth
- America Is Being Ripped Off: It's Time To Take Action Against Fraud & Foreign Exploitation
- Independence Title Honored for Excellence in Fraud Prevention by Stewart Title
- Dentaluxe's New Website Launch!
- PawTides.com Partners with Rescue 22 Foundation to Support Veterans and Rescue Dogs
- Pan-Armenian Digital Trade Center Launched on Fastexverse
- Stern Recruiting Launches with a Mission to Revolutionize Talent Acquisition
- Bonita Mitchell Releases Inspiring Single "Let This Mind Be In Me" From Book Soundtrack 'The First Lady'
- Webinar Announcement: Collaborating for Digital Transformation: Innovation, Governance, and the Future of Financial Operations
- ASI Holds Annual Executive Business Summit Showcasing Suite of Solutions & Celebrates 2024 Partner Award Winners
- Monogram Partners and Mulpha Win Prestigious Industry Award for Norwest Quarter
- Veterans for America First condemns a faith-based smear campaign against Muslim Candidate Sophia Farooq in Cobb County Georgia as Integrity Matters
- Nigeria is next biggest crypto-mining country - Oneminers is investing millions
- Corcoran DeRonja Real Estate Welcomes Mechelle Fuquay as Its Newest Broker
- Matt Stuckert Joins Lineus Medical Board of Directors
- Fray Fitness Launches Redesigned Website to Enhance Customer Experience
- ohGiGi® Wins Second Consecutive Sustainability Award, Addressing Plastic Waste in Oral Care
- Rampage Jackson and Rashad Evans Face Off At Press Conference At The Palms Casino Resort in Las Vegas on March 20, 2025
- Drone Light Shows Become the Must-Have Entertainment Trend for Events and Venues
- Multi-Million Dollar Contracts and Key Partnerships for Cybersecurity Solutions in the Rapidly Growing Market Nearing $200 Billion Annually $CYCU